Follow-On Biologics Theatre: Next Act Is FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
A House subcommittee hearing on FTC’s report on FOB competition includes yelling, a “challenge” to take an FOB product – and a promise from Chairman Pallone for more of the same.